An AMPK activator, Metformin, ameliorates aging-related oxidative hepatic injury induced by D-galactose via Irisin/ SIRT1 pathway, a possible role of PPAR-γ besides its antioxida

Anti-Diabetic Effects of Metformin Nanoemulsion and Cell-Based Therapy on the Insulin Signaling Pathway (IRS1/AKT) and Apoptotic Related Genes in Type 2 Diabetic Rat Model

METFORMIN ATTENUATES THIOACETAMIDE INDUCED HEPATOTOXIC EFFECTS IN RATS

IRISIN: A POTENTIAL PROMISING AGENT AGAINST NON-ALCOHOLIC FATTY LIVER DISEASE IN TYPE 2 DIABETIC RATS

Insulin sensitization via PPAR γ and glucose uptake through activation of PI3K/p-Akt signaling pathway by resveratrol in type 2 diabetic rats

Resveratrol and/or Metformin Activates Serum Sirtuin-1 and Decreases Insulin Resistance in High Fructose-Fed Rats

PPARγ UPREGULATION MEDIATES THE ANTIDIABETIC POTENTIAL OF KAEMPFEROL IN HIGH FAT DIET/STREPTOZOTOCIN-INDUCED DIABETIC RATS

Metformin versus losartan: prevention of non-alcoholic fatty liver disease in adult albino rats, an immunohistochemical study.

Pathophysiological mechanisms of type 2 diabetes mellitus and the effects of metformin treatment in adult male albino rats.

Effect of metformin on histopathological and immunohistochemical changes induced by high fructose intake in liver and brain of rats